Kyrospark Pharma Private Limited
About Kyrospark Pharma Private Limited
Data last updated:
Kyrospark Pharma Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the industrial products retail and distribution segment of the machinery and industrial equipment sector. It was incorporated on 02 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2019PTC318964. Its GSTIN is 27AAHCK4256A1ZR (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It was formerly known as Ksbl Pharma Private Limited. It is led by directors Suraj Yogendra Nandola (Managing Director) and Lloyd Vincent Baptista.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B/G – 4 Bageshree Chs Ltd Geeta Nagar Fatak Road Bhaindar East Thane, Maharashtra, India – 401105.
As per the financials filed for FY 2024, the company reported a revenue of ₹11.95 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹13,860 (net margin 1.2%) and EBITDA of ₹13,860 (EBITDA margin 1.2%). Revenue has grown at a compounded annual rate (CAGR) of 235% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressB/G – 4 Bageshree Chs Ltd Geeta Nagar Fatak Road Bhaindar East Thane, Maharashtra, India – 401105
- IndustryMachinery and Equipment, Industrial Products Retail & Distribution
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Kyrospark Pharma Private Limited
The main business activity of Kyrospark Pharma is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Kyrospark Pharma Private Limited FY 2025 filings available
Kyrospark Pharma Private Limited reported revenue of ₹11.95 Lakh (up 3930% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Kyrospark Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 235% over three years. EBITDA rose 716% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Kyrospark Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹13,860 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹13,860 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Kyrospark Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Kyrospark Pharma are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Kyrospark Pharma Private Limited
Kyrospark Pharma Private Limited is compared with the companies closest to it by revenue in the Machinery and Equipment industry (Industrial Products Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| HTB Infra Private Limited | ₹12.34 Lakh (FY 2025) | •••• | •••• | -71.0% | •••• | Gomti Nagar, Uttar Pradesh, India |
| New Phototech Private Limited | ₹12.24 Lakh (FY 2025) | •••• | •••• | -61.0% | •••• | Delhi, India |
| CL Promotions (OPC) Private Limited | ₹12.21 Lakh (FY 2020) | •••• | •••• | •••• | Deeg, Rajasthan, India | |
| Detsup Safety Private Limited | ₹12.18 Lakh (FY 2025) | •••• | •••• | •••• | Kalyan, Maharashtra, India | |
| Quatech Systems Private Limited | ₹12.03 Lakh (FY 2025) | •••• | •••• | •••• | Thane, Maharashtra, India | |
| Kyrospark Pharma Private Limited this company | ₹11.95 Lakh (FY 2024) | •••• | •••• | 3930.0% | •••• | Thane, Maharashtra, India |
| Habitat Hotels and Hospitality Private Limited | ₹11.84 Lakh (FY 2025) | •••• | •••• | -54.0% | •••• | Delhi, India |
| S J Valves Private Limited | ₹11.77 Lakh (FY 2024) | •••• | •••• | -48.0% | •••• | Ahmedabad, Gujarat, India |
| Xpert Gas Equipments Private Limited | ₹11.67 Lakh (FY 2024) | •••• | •••• | -83.0% | •••• | New Delhi, Delhi, India |
| Ignis Control Systems Private Limited | ₹11.2 Lakh (FY 2022) | •••• | •••• | 254.0% | •••• | Bangalore, Karnataka, India |
| Scaletron Equipments Private Limited | ₹11.15 Lakh (FY 2025) | •••• | •••• | •••• | Dadri, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Kyrospark Pharma by revenue in the Machinery and Equipment industry (Industrial Products Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Kyrospark Pharma Private Limited
Kyrospark Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suraj Yogendra Nandola | Managing Director | 02 Jan 2019 | 7 Years 9 Months | Current |
| Lloyd Vincent Baptista Also directs: 7Sparkyran Films LLP, Stypock Private Limited, Happiness Basket Private Limited and 1 more | Director | 02 Jan 2019 | 7 Years 9 Months | Current |
Ownership and Shareholding of Kyrospark Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Kyrospark Pharma Private Limited
Kyrospark Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Kyrospark Pharma Private Limited
Employment history and EPFO contributions of people linked to Kyrospark Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Kyrospark Pharma Private Limited
Kyrospark Pharma Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Bhavna Prakash Jain ceased to be Director on 02 Jul 2021.
Credit Ratings, Litigation & Regulatory Alerts for Kyrospark Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Kyrospark Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Kyrospark Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Kyrospark Pharma Private Limited
Kyrospark Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCK4256A1ZR | Maharashtra | Active | 27 Mar 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Kyrospark Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kyrospark Pharma Private Limited
Kyrospark Pharma is an active private limited company based in Thane, Maharashtra, India. The company works in industrial products retail and distribution, within the machinery and equipment industry. It was incorporated on 02 January 2019 (7+ years old) and is registered under CIN U74999MH2019PTC318964.
Kyrospark Pharma reported revenue of ₹11.95 Lakh for FY 2024 (up 3930% YoY).
Kyrospark Pharma has 2 current directors:
- Suraj Yogendra Nandola - Managing Director
- Lloyd Vincent Baptista - Director
Kyrospark Pharma reported a net profit of ₹13,860 (net margin 1.2%) and EBITDA of ₹13,860 (EBITDA margin 1.2%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Kyrospark Pharma is 235% over three years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Kyrospark Pharma is 27AAHCK4256A1ZR, registered in Maharashtra.
The CIN (Corporate Identification Number) of Kyrospark Pharma is U74999MH2019PTC318964. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kyrospark Pharma was incorporated on 02 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Kyrospark Pharma by revenue are HTB Infra Private Limited, New Phototech Private Limited, CL Promotions (OPC) Private Limited, Detsup Safety Private Limited, Quatech Systems Private Limited and 5 more, all in the Machinery and Equipment industry (Industrial Products Retail and Distribution).
Bhavna Prakash Jain ceased to be Director on 02 Jul 2021. Lloyd Vincent Baptista was appointed as Director on 02 Jan 2019. Suraj Yogendra Nandola was appointed as Managing Director on 02 Jan 2019.
The registered office of Kyrospark Pharma is at BG – 4 Bageshree Chs Ltd Geeta Nagar Fatak Road Bhaindar East Thane, Maharashtra, India – 401105.